Industry: Machinery & Equipment
Published Date: 2026-01-19
Pages: 88 Pages
Report ld: 5760797
Request Sample
Customized Report
Home Neuromodulation Device Market Size(US$)

CAGR 2026-2032
14.2%
Market Size,2032
USD 4,700
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Home Neuromodulation Device was estimated to be worth US$ 1879 million in 2025 and is projected to reach US$ 4700 million, growing at a CAGR of 14.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Home Neuromodulation Device cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user"s neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Home neuromodulation devices analyze users" physiological data through built-in algorithms or applications and provide feedback to users about their neurological status. This can be in real time or as a subsequent data analysis report. Future devices may pay more attention to the fusion of multi-modal data, combining brain waves, physiological indicators, behavioral data and other information to provide a more comprehensive analysis of neural status. These trends reflect the continuous innovation and development in technology, user experience and application expansion in the field of home neuromodulation devices.
This report provides a comprehensive view of the global market for Home Neuromodulation Device, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Home Neuromodulation Device market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Home Neuromodulation Device.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Home Neuromodulation Device manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Home Neuromodulation Device sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Home Neuromodulation Device sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Home Neuromodulation Device Product Introduction
1.2 Global Home Neuromodulation Device Market Size Forecast
1.2.1 Global Home Neuromodulation Device Sales Value (2021–2032)
1.2.2 Global Home Neuromodulation Device Sales Volume (2021–2032)
1.2.3 Global Home Neuromodulation Device Sales Price (2021–2032)
1.3 Home Neuromodulation Device Market Trends & Drivers
1.3.1 Home Neuromodulation Device Industry Trends
1.3.2 Home Neuromodulation Device Market Drivers & Opportunities
1.3.3 Home Neuromodulation Device Market Challenges
1.3.4 Home Neuromodulation Device Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Home Neuromodulation Device Players Revenue Ranking (2025)
2.2 Global Home Neuromodulation Device Revenue by Company (2021–2026)
2.3 Global Home Neuromodulation Device Sales Volume Ranking of Players (2025)
2.4 Global Home Neuromodulation Device Sales Volume by Company (2021–2026)
2.5 Global Home Neuromodulation Device Average Price by Company (2021–2026)
2.6 Key Manufacturers Home Neuromodulation Device Manufacturing Base and Headquarters
2.7 Key Manufacturers Home Neuromodulation Device Product Offerings
2.8 Key Manufacturers Start of Mass Production of Home Neuromodulation Device
2.9 Home Neuromodulation Device Market Competitive Analysis
2.9.1 Home Neuromodulation Device Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Home Neuromodulation Device Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Home Neuromodulation Device revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Home Neuromodulation Device Market Classification
3.1 Introduction by Type
3.1.1 Brain-Computer Interface Device
3.1.2 Neurofeedback Device
3.1.3 Brainwave Monitoring Equipment
3.1.4 Others
3.1.5 Global Home Neuromodulation Device Sales Value by Type
3.1.5.1 Global Home Neuromodulation Device Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Home Neuromodulation Device Sales Value, by Type (2021–2032)
3.1.5.3 Global Home Neuromodulation Device Sales Value, by Type (%), 2021–2032
3.1.6 Global Home Neuromodulation Device Sales Volume by Type
3.1.6.1 Global Home Neuromodulation Device Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Home Neuromodulation Device Sales Volume, by Type (2021–2032)
3.1.6.3 Global Home Neuromodulation Device Sales Volume, by Type (%), 2021–2032
3.1.7 Global Home Neuromodulation Device Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Aldult
4.1.2 Child
4.2 Global Home Neuromodulation Device Sales Value by Application
4.2.1 Global Home Neuromodulation Device Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Home Neuromodulation Device Sales Value, by Application (2021–2032)
4.2.3 Global Home Neuromodulation Device Sales Value, by Application (%), 2021–2032
4.3 Global Home Neuromodulation Device Sales Volume by Application
4.3.1 Global Home Neuromodulation Device Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Home Neuromodulation Device Sales Volume, by Application (2021–2032)
4.3.3 Global Home Neuromodulation Device Sales Volume, by Application (%), 2021–2032
4.4 Global Home Neuromodulation Device Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Home Neuromodulation Device Sales Value by Region
5.1.1 Global Home Neuromodulation Device Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Home Neuromodulation Device Sales Value by Region (2021–2026)
5.1.3 Global Home Neuromodulation Device Sales Value by Region (2027–2032)
5.1.4 Global Home Neuromodulation Device Sales Value by Region (%), 2021–2032
5.2 Global Home Neuromodulation Device Sales Volume by Region
5.2.1 Global Home Neuromodulation Device Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Home Neuromodulation Device Sales Volume by Region (2021–2026)
5.2.3 Global Home Neuromodulation Device Sales Volume by Region (2027–2032)
5.2.4 Global Home Neuromodulation Device Sales Volume by Region (%), 2021–2032
5.3 Global Home Neuromodulation Device Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Home Neuromodulation Device Sales Value, 2021–2032
5.4.2 North America Home Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Home Neuromodulation Device Sales Value, 2021–2032
5.5.2 Europe Home Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Home Neuromodulation Device Sales Value, 2021–2032
5.6.2 Asia Pacific Home Neuromodulation Device Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Home Neuromodulation Device Sales Value, 2021–2032
5.7.2 South America Home Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Home Neuromodulation Device Sales Value, 2021–2032
5.8.2 Middle East & Africa Home Neuromodulation Device Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Home Neuromodulation Device Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Home Neuromodulation Device Sales Value and Sales Volume
6.2.1 Key Countries/Regions Home Neuromodulation Device Sales Value, 2021–2032
6.2.2 Key Countries/Regions Home Neuromodulation Device Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Home Neuromodulation Device Sales Value, 2021–2032
6.3.2 United States Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Home Neuromodulation Device Sales Value, 2021–2032
6.4.2 Europe Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Home Neuromodulation Device Sales Value, 2021–2032
6.5.2 China Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.5.3 China Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Home Neuromodulation Device Sales Value, 2021–2032
6.6.2 Japan Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Home Neuromodulation Device Sales Value, 2021–2032
6.7.2 South Korea Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Home Neuromodulation Device Sales Value, 2021–2032
6.8.2 Southeast Asia Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Home Neuromodulation Device Sales Value, 2021–2032
6.9.2 India Home Neuromodulation Device Sales Value by Type (%), 2025 vs 2032
6.9.3 India Home Neuromodulation Device Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 NeuroSky
7.1.1 NeuroSky Company Information
7.1.2 NeuroSky Introduction and Business Overview
7.1.3 NeuroSky Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 NeuroSky Home Neuromodulation Device Product Offerings
7.1.5 NeuroSky Recent Developments
7.2 Emotiv
7.2.1 Emotiv Company Information
7.2.2 Emotiv Introduction and Business Overview
7.2.3 Emotiv Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Emotiv Home Neuromodulation Device Product Offerings
7.2.5 Emotiv Recent Developments
7.3 Muse
7.3.1 Muse Company Information
7.3.2 Muse Introduction and Business Overview
7.3.3 Muse Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Muse Home Neuromodulation Device Product Offerings
7.3.5 Muse Recent Developments
7.4 Thync
7.4.1 Thync Company Information
7.4.2 Thync Introduction and Business Overview
7.4.3 Thync Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Thync Home Neuromodulation Device Product Offerings
7.4.5 Thync Recent Developments
7.5 Halo Neuroscience
7.5.1 Halo Neuroscience Company Information
7.5.2 Halo Neuroscience Introduction and Business Overview
7.5.3 Halo Neuroscience Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Halo Neuroscience Home Neuromodulation Device Product Offerings
7.5.5 Halo Neuroscience Recent Developments
8 Industry Chain Analysis
8.1 Home Neuromodulation Device Industrial Chain
8.2 Home Neuromodulation Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Home Neuromodulation Device Sales Model
8.5.2 Sales Channels
8.5.3 Home Neuromodulation Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Home Neuromodulation Device market is projected to grow from US$ 1879 million in 2025 to US$ 4700 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 122
USD 4900.00
(Single User License)
The global Home Neuromodulation Device market size was US$ 1879 million in 2025 and is forecast to reach a readjusted size of US$ 4700 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 74
USD 4250.00
(Single User License)
The global Home Neuromodulation Device market was valued at US$ 1879 million in 2025 and is anticipated to reach US$ 4700 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published Date: 2026-01-16
Pages: 124
USD 2900.00
(Single User License)
The global Home Neuromodulation Device market is projected to grow from US$ 1666 million in 2024 to US$ 4168 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-02
Pages: 122
USD 4900.00
(Single User License)
The global Home Neuromodulation Device market size was US$ 1666 million in 2024 and is forecast to a readjusted size of US$ 4168 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published Date: 2025-03-09
Pages: 75
USD 4250.00
(Single User License)
The global market for Home Neuromodulation Device was estimated to be worth US$ 1666 million in 2024 and is forecast to a readjusted size of US$ 4168 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published Date: 2025-03-09
Pages: 87
USD 3950.00
(Single User License)
The global market for Home Neuromodulation Device was valued at US$ 1666 million in the year 2024 and is projected to reach a revised size of US$ 4168 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published Date: 2025-03-09
Pages: 76
USD 2900.00
(Single User License)
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published Date: 2024-02-08
Pages: 87
USD 4900.00
(Single User License)
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published Date: 2024-02-08
Pages: 105
USD 4350.00
(Single User License)
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published Date: 2024-02-08
Pages: 105
USD 3950.00
(Single User License)
The global Home Neuromodulation Device market is projected to grow from US$ 1879 million in 2025 to US$ 4700 million by 2032, at a CAGR of 14.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 122
The global Home Neuromodulation Device market size was US$ 1879 million in 2025 and is forecast to reach a readjusted size of US$ 4700 million by 2032 with a CAGR of 14.2% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 74
The global Home Neuromodulation Device market was valued at US$ 1879 million in 2025 and is anticipated to reach US$ 4700 million by 2032, at a CAGR of 14.2% from 2026 to 2032.
Published: 2026-01-16
Pages: 124
The global Home Neuromodulation Device market is projected to grow from US$ 1666 million in 2024 to US$ 4168 million by 2031, at a CAGR of 14.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-02
Pages: 122
The global Home Neuromodulation Device market size was US$ 1666 million in 2024 and is forecast to a readjusted size of US$ 4168 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published: 2025-03-09
Pages: 75
The global market for Home Neuromodulation Device was estimated to be worth US$ 1666 million in 2024 and is forecast to a readjusted size of US$ 4168 million by 2031 with a CAGR of 14.2% during the forecast period 2025-2031.
Published: 2025-03-09
Pages: 87
The global market for Home Neuromodulation Device was valued at US$ 1666 million in the year 2024 and is projected to reach a revised size of US$ 4168 million by 2031, growing at a CAGR of 14.2% during the forecast period.
Published: 2025-03-09
Pages: 76
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published: 2024-02-08
Pages: 87
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published: 2024-02-08
Pages: 105
Home neuromodulation equipment is a type of portable device designed specifically for home users. It monitors, analyzes and adjusts the user's neural activity or physiological indicators to achieve goals such as promoting mental health, improving cognitive ability, and improving sleep. These devices often use brain-computer interface technology, biofeedback technology, or neurostimulation technology to enable users to more proactively manage their neurological status.
Published: 2024-02-08
Pages: 105
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now